Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | FAAH | O00519 | 3/20 | 0.41 |
| ▸ | MGLL | Q99685 | 2/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.40 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18133543 | 1.00 | CYP1A2 (0.59) | CYP1A2ALDH1A1TSHRFAAHMGLL | |
| SCHEMBL2597399 | 1.00 | CYP1A2 (0.59) | CYP1A2ALDH1A1TSHRFAAHMGLL | |
| SCHEMBL2901282 | 1.00 | CYP1A2 (0.59) | CYP1A2ALDH1A1TSHRFAAHMGLL | |
| SCHEMBL10339907 | 0.98 | CYP1A2 (0.62) | CYP1A2ALDH1A1TSHRFAAHMGLL | |
| SCHEMBL10339908 | 0.98 | CYP1A2 (0.62) | CYP1A2ALDH1A1TSHRFAAHMGLL | |
| SCHEMBL10339906 | 0.98 | CYP1A2 (0.62) | CYP1A2ALDH1A1TSHRFAAHMGLL | |
| SCHEMBL27968096 | 0.89 | CYP1A2 (0.51) | CYP1A2ALDH1A1TSHRPPARG | |
| SCHEMBL1716637 | 0.88 | CYP1A2 (0.50) | CYP1A2ALDH1A1TSHRFAAHMGLL | |
| SCHEMBL2597391 | 0.83 | CYP1A2 (0.66) | CYP1A2ALDH1A1TSHRFAAHMGLL | |
| SCHEMBL31048000 | 0.83 | CYP1A2 (0.66) | CYP1A2ALDH1A1TSHRFAAHMGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 182 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025235687-A1 | LRRK2 INHIBITORS | Brenig Therapeutics, Inc. (US) | 2025-11-13 | — | — | WO | claimed |
| EP-4637738-A2 | INHIBITORS OF JAK2 | Llydaw Therapeutics, Inc. (US) | 2025-10-29 | — | — | EP | claimed |
| US-20250212873-A1 | VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-07-03 | — | — | US | claimed |
| EP-4482306-A1 | VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-01-01 | — | — | EP | claimed |
| WO-2023192424-A1 | VOLATILE HD AC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS CROSS-REFERENCE TO RELATED APPLICATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-10-05 | — | — | WO | claimed |
| EP-3649183-A1 | SILICONE COMPOUNDS | The Procter and Gamble Company (US) | 2020-05-13 | — | — | EP | claimed |
| EP-3649184-A1 | SILICONE COMPOUNDS | The Procter and Gamble Company (US) | 2020-05-13 | — | — | EP | claimed |
| WO-2019010265-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 2019-01-10 | — | — | WO | claimed |
| WO-2019010263-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 2019-01-10 | — | — | WO | claimed |
| US-20190010427-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY | 2019-01-10 | — | — | US | claimed |
| US-9167838-B2 | Infant formulation containing an aroma composition for use as fragrance | FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 2015-10-27 | — | — | US | claimed |
| EP-2154997-B1 | IMPROVED INFANT FORMULA CONTAINING AN AROMA COMPOSITION FOR USE AS FRAGRANCE | FRAUNHOFER GES FORSCHUNG (DE) | 2015-07-08 | — | — | EP | claimed |
| US-20100137595-A1 | VAGINAL ODORANTS | FRAUNHOFER-GESELLSHCAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 2010-06-03 | — | — | US | claimed |
| US-20100129312-A1 | INFANT FORMULA CONTAINING AN AROMA COMPOSITION FOR USE AS FRAGRANCE | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2010-05-27 | — | — | US | claimed |
| EP-2167195-A1 | VAGINAL ODORANTS | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2010-03-31 | — | — | EP | claimed |
| EP-2154997-A2 | IMPROVED INFANT FORMULA CONTAINING AN AROMA COMPOSITION FOR USE AS FRAGRANCE | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2010-02-24 | — | — | EP | claimed |
| US-20090169652-A1 | Personal Care Compositions | THE PROCTER & GAMBLE COMPANY | 2009-07-02 | — | — | US | claimed |
| WO-2009003935-A1 | VAGINAL ODORANTS | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2009-01-08 | — | — | WO | claimed |
| EP-2008691-A1 | Vaginal odorants | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2008-12-31 | — | — | EP | claimed |
| WO-2008138547-A2 | IMPROVED INFANT FORMULA CONTAINING AN AROMA COMPOSITION FOR USE AS FRAGRANCE | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2008-11-20 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090169652-A1 | Personal Care Compositions | CUTA, C5, F7 | CYP1A2 2799/4885ALDH1A1 3550/4885TSHR 4683/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.